Strides Pharma recalls Cinacalcet Tablets 30 mg because they failed dissolution specifications
The 30 mg Cinacalcet Tablets in 30-count bottles failed dissolution specifications, and 49,488 bottles were distributed across the US.
What to do
Check whether you have Cinacalcet Tablets, 30 mg, 30-count bottle, NDC 64380-883-04, made for Strides Pharma Inc. The notice does not give other instructions, so read the official notice for details.
Note from Recalled Today: Don't stop taking a prescribed medicine before you talk to your pharmacist or doctor.
Recall details
- Product
- Cinacalcet Tablets, 30 mg, 30-count bottle, Rx only, Manufactured by: Strides Pharma Science Ltd. Puducherry, 605 014, India; Distributed by: Strides Pharma Inc. Bridgewater, NJ 08807, NDC 64380-883-04
- Company
- Strides Pharma INC
- Hazard
- Failed dissolution specifications
- Units
- 49,488 30-count bottles
- Where sold
- US Nationwide
- FDA classification
- Class II · Ongoing
- Classified by FDA
- October 26, 2026
- Recall started
- October 7, 2026
- FDA enforcement report
- October 28, 2026
- Identifiers
- Codes: Lot # 7717825A, Expiry: 11/30/2028.
- FDA recall number: D-0079-2027
The headline, summary and steps above are written in plain English from the official notice below. Identifiers are copied exactly as the agency published them. Always check the official notice before you act.
Official notice
The notice's own wording from FDA.
- Product
- Cinacalcet Tablets, 30 mg, 30-count bottle, Rx only, Manufactured by: Strides Pharma Science Ltd. Puducherry, 605 014, India; Distributed by: Strides Pharma Inc. Bridgewater, NJ 08807, NDC 64380-883-04
- Reason for recall
- Failed dissolution specifications
- Classification
- Class II (Ongoing)
- Distribution
- US Nationwide
- Quantity
- 49,488 30-count bottles
Related recalls
Strides Pharma recalls Children's Ibuprofen Oral Suspension 100 mg per 5mL over gel-like mass and black particles
The company received complaints that bottles of this children's ibuprofen liquid contained a gel-like mass and black particles, meaning a foreign substance is in the medicine.
Strides Pharma INC · 89592 bottles
Greenwich Rx recalls Glutathione Injection 10 mL vials over microbial contamination
The notice says the sterile Glutathione Injection (200 mg/mL, 10 mL multi-dose vial, Subcutaneous Only) has microbial contamination, and 4,319 vials were sent across the US.
Greenwich Rx · 4,319 vials
Pritam International recalls Brush Buddies and evo toothpastes over manufacturing practice problems
The notice says these anticavity fluoride toothpastes were made with deviations from current good manufacturing practices and were distributed across the US.
Pritam International Private Limited · 3,309,696 units
Viatris recalls telmisartan and amlodipine tablets because telmisartan content may be too high
The tablets may contain more telmisartan than they are supposed to, so the content in these lots could go over the limit set for the product.
Viatris, Inc. · 21,620 30-count bottles
Pfizer recalls Levoxyl 175 mcg levothyroxine sodium tablets over weaker-than-labeled strength
The tablets are subpotent, meaning they are weaker than labeled, after a stability test confirmed an out-of-specification assay result.
Pfizer · 15,949 units
Ascend Laboratories recalls amlodipine and olmesartan medoxomil tablets because they failed a dissolution test
The 10mg/40mg tablets, sold in 30-tablet bottles, were found to be out of specification due to dissolution, and 11,424 bottles were distributed nationwide within the United States.
Ascend Laboratories, LLC · 11,424 bottles.